Background Sleep disturbance is associated with inflammatory disease risk and all-cause
mortality. Here, we assess global evidence linking sleep disturbance, sleep duration, and …

Fatigue is one of the most common adverse effects of cancer that might persist for years after
treatment completion in otherwise healthy survivors. Cancer-related fatigue causes …

Cytokines are highly inducible, secretory proteins that mediate intercellular communication
in the immune system. They are grouped into several protein families that are referred to as …

Introduction: Sleep disorders, especially insomnia, are very common in different kinds of
cancers, but their prevalence and incidence are not well-known. Disturbed sleep in cancer is …

Introduction Neo/adjuvant therapy for early-stage breast cancer has become increasingly
common in the last few decades; as a consequence, the number of breast cancer survivors …

Purpose Understanding the etiology of cancer-related fatigue (CRF) is critical to identify
targets to develop therapies to reduce CRF burden. The goal of this systematic review was …

Sleep disturbance is one of the most common and troubling symptoms that harm the quality
of life throughout all phases of treatment and stages of the illness among patients with …

Chronic or persistent fatigue is a common, debilitating symptom of several diseases.
Persistent fatigue has been associated with low-grade inflammation in several models of …

Fatigue is a highly disabling symptom in various medical conditions. While inflammation has
been suggested as a potential contributor to the development of fatigue, underlying …

The circadian timing system (CTS) controls several critical molecular pathways for cancer
processes and treatment effects over the 24 hours, including drug metabolism, cell cycle …